AU Patent

AU2002247019B9 — Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications

Assigned to Organon LLC · Expires 2007-03-08 · 19y expired

What this patent protects

Patent listed against Zetia.

Drugs covered by this patent

Zetia (EZETIMIBE) · Merck & Co.

Patent Metadata

Patent number: AU2002247019B9
Jurisdiction: AU
Classification: —
Expires: 2007-03-08
Drug substance claim: No
Drug product claim: No
Assignee: Organon LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.